Literature DB >> 27329446

Fighting MRSA Infections in Hospital Care: How Organizational Factors Matter.

Torsten Oliver Salge1, Antonio Vera2, David Antons1, Jeannie P Cimiotti3.   

Abstract

OBJECTIVE: To identify factors associated with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections at the level of the hospital organization. DATA SOURCES: Data from all 173 acute trusts in the English National Health Service (NHS). STUDY
DESIGN: A longitudinal study based on trust-level panel data for the 5-year period from April 2004 to March 2009. Fixed effects negative binominal and system generalized method of moment models were used to examine the effect of (i) patient mix characteristics, (ii) resource endowments, and (iii) infection control practices on yearly MRSA counts. DATA COLLECTION: Archival and staff survey data from multiple sources, including Public Health England, the English Department of Health, and the Healthcare Commission, were merged to form a balanced panel dataset. PRINCIPAL
FINDINGS: MRSA infections decrease with increases in general cleaning (-3.52 MRSA incidents per 1 standard deviation increase; 95 percent confidence interval: -6.61 to -0.44), infection control training (-3.29; -5.22 to -1.36), hand hygiene (-2.72; -4.76 to -0.68), and error reporting climate (-2.06; -4.09 to -0.04).
CONCLUSIONS: Intensified general cleaning, improved hand hygiene, additional infection control training, and a climate conducive to error reporting emerged as the factors most closely associated with trust-level reductions in MRSA infections over time. © Health Research and Educational Trust.

Entities:  

Keywords:  zzm321990MRSAzzm321990; Health care-associated infections; National Health Service; panel data

Mesh:

Year:  2016        PMID: 27329446      PMCID: PMC5441483          DOI: 10.1111/1475-6773.12521

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  54 in total

1.  MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.

Authors:  David H Wyllie; Tim E A Peto; Derrick Crook
Journal:  BMJ       Date:  2005-09-09

2.  A panel data study of physicians' labor supply: the case of Norway.

Authors:  Badi H Baltagi; Espen Bratberg; Tor Helge Holmås
Journal:  Health Econ       Date:  2005-10       Impact factor: 3.046

Review 3.  Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system.

Authors:  Eyal Zimlichman; Daniel Henderson; Orly Tamir; Calvin Franz; Peter Song; Cyrus K Yamin; Carol Keohane; Charles R Denham; David W Bates
Journal:  JAMA Intern Med       Date:  2013 Dec 9-23       Impact factor: 21.873

Review 4.  Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs.

Authors:  Craig A Umscheid; Matthew D Mitchell; Jalpa A Doshi; Rajender Agarwal; Kendal Williams; Patrick J Brennan
Journal:  Infect Control Hosp Epidemiol       Date:  2011-02       Impact factor: 3.254

5.  The role of nurse understaffing in nosocomial viral gastrointestinal infections on a general pediatrics ward.

Authors:  Jacob Stegenga; Erica Bell; Anne Matlow
Journal:  Infect Control Hosp Epidemiol       Date:  2002-03       Impact factor: 3.254

6.  Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants.

Authors:  Rupak Datta; Richard Platt; Deborah S Yokoe; Susan S Huang
Journal:  Arch Intern Med       Date:  2011-03-28

Review 7.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat.

Authors:  Hajo Grundmann; Marta Aires-de-Sousa; John Boyce; Edine Tiemersma
Journal:  Lancet       Date:  2006-09-02       Impact factor: 79.321

8.  Health care-associated invasive MRSA infections, 2005-2008.

Authors:  Alexander J Kallen; Yi Mu; Sandra Bulens; Arthur Reingold; Susan Petit; Ken Gershman; Susan M Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; William Schaffner; Priti R Patel; Scott K Fridkin
Journal:  JAMA       Date:  2010-08-11       Impact factor: 56.272

9.  Active surveillance to determine the impact of methicillin resistance on mortality in patients with bacteremia and influences of the use of antibiotics on the development of MRSA infection.

Authors:  Juliana Pena Porto; Rosana Oliveira Santos; Paulo Pinto Gontijo Filho; Rosineide Marques Ribas
Journal:  Rev Soc Bras Med Trop       Date:  2013 Nov-Dec       Impact factor: 1.581

10.  Substantial shifts in ranking of California hospitals by hospital-associated methicillin-resistant Staphylococcus aureus infection following adjustment for hospital characteristics and case mix.

Authors:  David M Tehrani; Michael J Phelan; Chenghua Cao; John Billimek; Rupak Datta; Hoanglong Nguyen; Homin Kwark; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2014-09-02       Impact factor: 3.254

View more
  4 in total

Review 1.  Does a hospital culture influence adherence to infection prevention and control and rates of healthcare associated infection? A literature review.

Authors:  Adriana van Buijtene; Dona Foster
Journal:  J Infect Prev       Date:  2018-11-09

2.  A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus.

Authors:  Hamed Haddad Kashani; Hossein Fahimi; Yasaman Dasteh Goli; Rezvan Moniri
Journal:  Front Cell Infect Microbiol       Date:  2017-06-30       Impact factor: 5.293

3.  Understanding institutional stakeholders' perspectives on multidrug-resistant bacterial organism at the end of life: a qualitative study.

Authors:  Maria Heckel; Franziska A Herbst; Thomas Adelhardt; Johanna M Tiedtke; Alexander Sturm; Stephanie Stiel; Christoph Ostgathe
Journal:  Clin Interv Aging       Date:  2017-10-03       Impact factor: 4.458

4.  Characterization of a New Staphylococcus aureus Kayvirus Harboring a Lysin Active against Biofilms.

Authors:  Luís D R Melo; Ana Brandão; Ergun Akturk; Silvio B Santos; Joana Azeredo
Journal:  Viruses       Date:  2018-04-07       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.